Sterling Capital Management’s Avidity Biosciences RNAM Stock Holding History

Sterling Capital Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,237	Closed	-$89.2K	–	3248
2025 Q4	$89.2K	Buy	1,237 +438	+55%	+$28.3K	﹤0.01%	1575
2025 Q3	$34.8K	Buy	799 +294	+58%	+$11.9K	﹤0.01%	1900
2025 Q2	$14.3K	Buy	505 +385	+321%	+$11.5K	﹤0.01%	1928
2025 Q1	$3.54K	Buy	120 +5	+4%	+$156	﹤0.01%	2323
2024 Q4	$3.34K	Buy	115 +4	+4%	+$167	﹤0.01%	2615
2024 Q3	$5.1K	Buy	+111	New	+$4.82K	﹤0.01%	1756

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Sterling Capital Management's RNAM Position: Q1 2026 in Review

Sterling Capital Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 1,237 shares — an estimated $89.2K sold.

Sterling Capital Management first reported a position in RNAM in Q3 2024 and held it in 6 quarters. The position peaked at $89.2K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Sterling Capital Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Sterling Capital Management sold 1,237 Avidity Biosciences shares in Q1 2026, an estimated $89.2K.
Sterling Capital Management first reported a position in Avidity Biosciences in Q3 2024 and held it in 6 quarters.
Sterling Capital Management's Avidity Biosciences position peaked at $89.2K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Sterling Capital Management's 13F filing for Q1 2026, filed 22 Apr 2026.